Rich Wojcik was recently named a Top 25 CFO of San Antonio by Top CFOs. Wojcik oversees all financial planning, accounting, audits, and investor relations, ensuring the company's financial strength and operational efficiency. Prytime Medical is helping expand the use of Prolonged REBOA ™ domestically and internationally.
SAN ANTONIO, April 30, 2024 /PRNewswire-PRWeb/ -- Prytime Medical Devices Inc, The REBOA Company™, the leading innovator and global provider of lifesaving REBOA products for hemorrhage control, is excited to announce that Rich Wojcik was recently named a Top 25 CFO of San Antonio by Top CFOs. Wojcik, who brings a wealth of finance experience and a strong strategic planning background, is a critical member of the leadership team helping position Prytime's future expansion and growth.
"Congratulations to Rich for this major accomplishment and for representing Prytime so well in a highly competitive and distinguished field," said David Spencer, CEO of Prytime Medical. "Rich's extensive financial background and proven ability to drive profitable growth make him the ideal CFO at this stage of our company's development. His expertise will be crucial as we expand our penetration in the civilian and military markets. His track record of skillfully bolstering the financial needs of growing companies will help Prytime expand as our customers continue adopting the use of Prolonged REBOA ™ both domestically and internationally. We're proud of his accomplishments and commend him on this well-deserved honor."
"I'm thrilled for this recognition and to be in this group of world-class honorees," said Wojcik. "I was excited to join Prytime Medical during this period of growth and innovation. I look forward to working closely with this talented team to drive financial performance and make a significant impact on patients' access to our products. The opportunity to support the company's mission that no one should bleed to death is incredibly motivating and rewarding. Thank you to Top CFOs for the honor."
With more than two decades of experience in finance and accounting across various industries, Wojcik's previous roles include CFO at Capital Precast Holdings and CaptureRX where he overhauled and centralized benefits programs, improved the financial health of the organizations, and supported business expansion. As CFO at Prytime, he oversees all financial planning, accounting, audits, and investor relations, ensuring the company's financial strength and operational efficiency.
Rich Wojcik earned a Master of Business Administration in accounting from St. Edwards University in Austin, TX, and a Bachelor of Science in management with a minor in economics from California State University, Chico.
About Prytime Medical Devices, Inc.
Prytime Medical™ Devices, Inc. is an innovative medical device company that designs, develops, and commercializes minimally invasive solutions for hemorrhage control. Inspired by our continued work with the military, both in the U.S. and abroad, Prytime Medical is dedicated to saving lives through its pioneering technology. We believe that no one should bleed to death and our product portfolio includes the industry-leading ER-REBOA PLUS™ catheter as well as the innovative pREBOA-PRO™ Partial REBOA Catheter. The pREBOA-PRO™ catheter is the first and only FDA-cleared REBOA catheter designed specifically for True Partial REBOA™. It enables Prolonged REBOA™ buying physicians time to treat while providing central aortic pressure monitoring with safe partial aortic occlusion times up to two hours. For more information, visit: http://www.PrytimeMedical.com.
Media Contact
Jeff Sossamon, Prytime Medical Devices, Inc., 573-808-1751, jsossamon@prytimemedical.com, prytimemedical.com
SOURCE Prytime Medical Devices, Inc.
Share this article